Characteristics and Outcome of Patients with or without Previous Implantable Cardioverter Defibrillator Interventions Undergoing Ablation for Ventricular Tachycardia

被引:0
|
作者
Bencardino, Gianluigi [1 ]
Narducci, Maria Lucia [1 ]
Scacciavillani, Roberto [1 ,2 ]
Gabrielli, Francesca Augusta [1 ]
Pelargonio, Gemma [1 ,2 ]
Massetti, Massimo [1 ,2 ]
Crea, Filippo [1 ,2 ]
Lanza, Gaetano Antonio [1 ]
机构
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc & Thorac Sci, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Cardiol Inst, I-00136 Rome, Italy
关键词
ventricular arrhythmias; catheter ablation; electrical storm; CATHETER ABLATION;
D O I
10.3390/jcm13164958
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Catheter ablation (CA) is a well-established treatment in patients with ventricular tachycardia and appropriate implantable cardioverter defibrillator (ICD) therapies. Methods: We enrolled 57 consecutive carriers of ICD undergoing CA for electrical storm (ES). Our aim was to investigate differences in clinical, device-related, and electroanatomic features among patients who had history of appropriate ICD interventions before the ES compared to those who had not. The primary endpoint was a composite of death from any cause and recurrences of sustained VT, ventricular fibrillation, appropriate ICD therapy, or ES. Results: During a median follow up of 39 months, 28 patients (49%) met the primary endpoint. Those with previous ICD interventions had a higher prevalence of late potentials and a greater unipolar low-voltage area at electroanatomic mapping. Patients who met the primary endpoint had a higher prevalence of ATP/shock episodes preceding the ES event. At Cox regression analysis, non-ischemic dilated cardiomyopathy (NIDCM), QRS duration, and previous ATP and/or shock before the ES were associated with arrhythmic recurrences and/or death. At multivariate analysis, NIDCM and previous shock were associated with arrhythmic recurrences and/or death. Conclusions: A history of recurrent ICD therapies predicts worse outcomes when CA is needed because of ES. Although more studies are needed to definitively address this question, our data speak in support of an early referral for CA of ES.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot Trial
    Al-Khatib, Sana M.
    Daubert, James P.
    Anstrom, Kevin J.
    Daoud, Emile G.
    Gonzalez, Mario
    Saba, Samir
    Jackson, Kevin P.
    Reece, Tammy
    Gu, Joan
    Pokorney, Sean D.
    Granger, Christopher B.
    Hess, Paul L.
    Mark, Daniel B.
    Stevenson, William G.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2015, 26 (02) : 151 - 157
  • [2] Outcome of patients with haemodynamically stable ventricular tachycardia treated with an implantable cardioverter-defibrillator
    Kolettis, Theofilos M.
    Krikos, Vassils D.
    Apostolidis, Dimitris
    Naka, Katerina K.
    Katsouras, Christos S.
    Sourla, Eleni
    Michalis, Lampros K.
    HELLENIC JOURNAL OF CARDIOLOGY, 2008, 49 (04) : 248 - 259
  • [3] Reproducibility of ventricular fibrillation characteristics in patients undergoing implantable cardioverter defibrillator implantation
    Taneja, T
    Goldberger, J
    Parker, MA
    Johnson, D
    Robinson, N
    Horvath, G
    Kadish, AH
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1997, 8 (11) : 1209 - 1217
  • [4] Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator
    Sauer, William H.
    Zado, Erica
    Gerstenfeld, Edward P.
    Marchlinski, Francis E.
    Callans, David J.
    HEART RHYTHM, 2010, 7 (01) : 9 - 14
  • [5] Implantable cardioverter defibrillator detection during radiofrequency catheter ablation of ventricular tachycardia
    Hammerschmidt, S
    Cao, KJ
    Schaumann, A
    Krieglstein, H
    Gonska, BD
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (09): : 1388 - 1390
  • [6] Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter-defibrillator?
    Estes, N. A. Mark, III
    HEART RHYTHM, 2022, 19 (09) : 1573 - 1573
  • [7] Incidence and relevance of nonreentrant monomorphic ventricular tachycardia in patients with frequent implantable cardioverter defibrillator interventions
    Michael Fiek
    Thomas Remp
    Martin Fleckenstein
    Tilman Pohl
    Michael Deiss
    Christopher Reithmann
    Journal of Interventional Cardiac Electrophysiology, 2015, 42 : 151 - 160
  • [8] Incidence and relevance of nonreentrant monomorphic ventricular tachycardia in patients with frequent implantable cardioverter defibrillator interventions
    Fiek, Michael
    Remp, Thomas
    Fleckenstein, Martin
    Pohl, Tilman
    Deiss, Michael
    Reithmann, Christopher
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2015, 42 (02) : 151 - 160
  • [9] Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy
    Gandjbakhch, Estelle
    Laredo, Mikael
    Berruezo, Antonio
    Gourraud, Jean-Basptiste
    Sellal, Jean-Marc
    Martins, Raphael
    Sacher, Frederic
    Pison, Laurent
    Pruvot, Etienne
    Jauregui, Beatriz
    Frontera, Antonio
    Kumar, Saurabh
    Wong, Tom
    DellaBella, Paolo
    Maury, Philippe
    EUROPACE, 2021, 23 (09): : 1428 - 1436
  • [10] Early statin therapy reduces risk of ICD shocks in patients with an implantable cardioverter-defibrillator undergoing ablation for ventricular tachycardia
    Bunch, T. J.
    Friedman, Paul A.
    Gersh, Bernard J.
    Asirvatham, Samuel J.
    Brady, Peter A.
    Chia, Yong-Mei
    Jahangir, Arshad
    Hammill, Stephen C.
    Monahan, Kristi
    Munger, Thomas M.
    Rea, Robert F.
    Shen, Win K.
    Tabatabaei, Niloufar
    Packer, Douglas L.
    CIRCULATION, 2007, 116 (16) : 320 - 320